Academic Articles

2016

Barratt, M.J., Ferris, J.A. and Winstock, A.R., 2016. Safer scoring? Cryptomarkets, social supply and drug market violence. International Journal of Drug Policy.

Kaar, S.J., Ferris, J., Waldron, J., Devaney, M., Ramsey, J. and Winstock, A.R., 2016. Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. Journal of Psychopharmacology, 30(4), pp.395-401.

Hindocha, C., Freeman, T.P., Winstock, A.R. and Lynskey, M.T., 2016. Vaping cannabis (marijuana) has the potential to reduce tobacco smoking in cannabis users. Addiction, 111(2), pp.375-375.

2015

Bellis, M.A., Quigg, Z., Hughes, K., Ashton, K., Ferris, J. and Winstock, A., 2015. Harms from other people’s drinking: an international survey of their occurrence, impacts on feeling safe and legislation relating to their control. BMJ open, 5(12), p.e010112.

Winstock, A., Lynskey, M., Borschmann, R. and Waldron, J., 2015. Risk of emergency medical treatment following consumption of cannabis or synthetic cannabinoids in a large global sample. Journal of Psychopharmacology, 29(6), pp.698-703.

Morley, K.I., Lynskey, M.T., Moran, P., Borschmann, R. and Winstock, A.R., 2015. Polysubstance use, mental health and high?risk behaviours: Results from the 2012 Global Drug Survey. Drug and alcohol review, 34(4), pp.427-437.

Winstock, A., 2015. New health promotion for chemsex and ?-hydroxybutyrate (GHB). BMJ, 351, p.h6281.

Uosukainen, H., Tacke, U. and Winstock, A.R., 2015. Self-reported prevalence of dependence of MDMA compared to cocaine, mephedrone and ketamine among a sample of recreational poly-drug users. International Journal of Drug Policy, 26(1), pp.78-83.

Stevens, A., Barratt, M., Lenton, S., Ridout, M. and Winstock, A., 2015. Social Bias in the Policing of Illicit Drug Users in the UK and Australia: Findings from a Self-Report Study. Available at SSRN 2618393.

Garnett, C., Crane, D., West, R., Michie, S., Brown, J. and Winstock, A., 2015. Normative misperceptions about alcohol use in the general population of drinkers: A cross-sectional survey. Addictive behaviors, 42, pp.203-206.

Shiner, M. and Winstock, A., 2015. Drug use and social control: The negotiation of moral ambivalence. Social Science & Medicine, 138, pp.248-256.

Freeman, T.P. and Winstock, A.R., 2015. Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological medicine, 45(15), pp.3181-3189 .

Winstock, A.R., Lawn, W., Deluca, P. and Borschmann, R., 2015. Methoxetamine: An early report on the motivations for use, effect profile and prevalence of use in a UK clubbing sample. Drug and alcohol review.

2014

Lawn, W., Barratt, M., Williams, M., Horne, A. and Winstock, A., 2014. The NBOMe hallucinogenic drug series: patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology, 28(8), pp.780-788.

Barratt, M.J., Ferris, J.A. and Winstock, A.R., 2014. Use of Silk Road, the online drug marketplace, in the United Kingdom, Australia and the United States. Addiction, 109(5), pp.774-783.

Winstock, A.R., Borschmann, R. and Bell, J., 2014. The non?medical use of tramadol in the UK: findings from a large community sample. International journal of clinical practice, 68(9), pp.1147-1151.

2013

Winstock, A.R., Kaar, S. and Borschmann, R., 2013. Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample. Journal of Psychopharmacology, p.0269881113513852.

Archer, J.R.H., Dargan, P.I., Wood, D.M. and Winstock, A.R., 2013. Hospital and prehospital emergency service utilisation as an impact of acute recreational drug and ethanol toxicity. Journal of Substance Use, 18(2), pp.129-137

Winstock, A.R. and Barratt, M.J., 2013. The 12?month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products. Human Psychopharmacology: Clinical and Experimental, 28(4), pp.390-393.

Winstock, A.R. and Barratt, M.J., 2013. Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and alcohol dependence, 131(1), pp.106-111.

Winstock, A., Bell, J. and Borschmann, R., 2013. Friends, doctors, and tramadol: we might have a problem. BMJ, 347, p.f5599.

 2012

Hughes, B. and Winstock, A.R., 2012. Controlling new drugs under marketing regulations. Addiction, 107(11), pp.1894-1899. h

Winstock, A.R. and Mitcheson, L., 2012. New recreational drugs and the primary care approach to patients who use them. BMJ, 344, p.e288.

Winstock, A.R., Mitcheson, L., Gillatt, D.A. and Cottrell, A.M., 2012. The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU international, 110(11), pp.1762-1766

2011

Winstock, A. and Wilkins, C., 2011. ‘Legal highs’: the challenge of new psychoactive substances. TNI/IDPC Transnational Institute Series on Legislative Reform of Drug Policies, (16).

Winstock, A.R., Mitcheson, L.R., Deluca, P., Davey, Z., Corazza, O. and Schifano, F., 2011. Mephedrone, new kid for the chop?. Addiction, 106(1), pp.154-161.

Winstock, A., Mitcheson, L., Ramsey, J., Davies, S., Puchnarewicz, M. and Marsden, J., 2011. Mephedrone: use, subjective effects and health risks. Addiction, 106(11), pp.1991-1996.

2010

Winstock, A., Mitcheson, L. and Marsden, J., 2010. Mephedrone: still available and twice the price. The Lancet, 376(9752), p.1537.

Winstock, A.R., Marsden, J. and Mitcheson, L., 2010. What should be done about mephedrone?. Bmj, 340, p.c1605.

Winstock, A.R. and Ramsey, J.D., 2010. Legal highs and the challenges for policy makers. Addiction, 105(10), pp.1685-1687.

Winstock, A.R. and Marsden, J., 2010. Mephedrone: Assessment of Health Risks and Harms. European Monitoring Centre for Drugs and Drug Addiction. Risk Assessment Report of a New Psychoactive Substance: 4-methylmethcathinone (mephedrone). EMCDDA: Lisbon.

Pre 2010 methods papers

McCambridge, J., Winstock, A., Hunt, N. and Mitcheson, L., 2007. 5-Year trends in use of hallucinogens and other adjunct drugs among UK dance drug users. European addiction research, 13(1), pp.57-64.

McCambridge, J., McCambridge, J., Mitcheson, L., Hunt, N. and Winstock, A., 2006. The rise of Viagra among British illicit drug users: 5-year survey data. Drug and alcohol review, 25(2), pp.111-113.

McCambridge, J., Mitcheson, L., Winstock, A. and Hunt, N., 2005. Five?year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction, 100(8), pp.1140-1149.

Winstock, A.R., Griffiths, P. and Stewart, D., 2001. Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK. Drug and alcohol dependence, 64(1), pp.9-17.